Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |